cures-within-reach1-original-blue-green.jpg

April 2016  
​News and Events


d4eb1ade95354b84b086d47cf822dfc7.png


​June 21, 2016

The Montgomery Club
500 W. Superior Street
Chicago, IL 60654


6pm Reception
7pm Dinner Program 


Sponsors include Celgene, Takeda Pharmaceuticals, PwC, Horizon Pharma plc, Aptinyx inc, HuLow Medical, Rediscovery Life Sciences, Camargo Pharmaceuticals

2016 Awardees

2016awardees.jpg


From November through February, we asked our research community to share their best repurposing research ideas ready for proof of concept testing, trying to get 100 projects in 100 days posted onto our CureAccelerator™ platform.

We reached our goal!  Register as a user, and see repurposing projects posted from around the globe on CureAccelerator.

100-projects-v1-200.png


Would you golf all day to save lives?

Join us for the Longest Day of Golf, a golf event like no other!
Play from dawn til dusk and raise funds for research that can change lives today.

37e1a21878a44917a950bf0a7e2944dc.png


SSIR-Logo-2013.jpg

Repurposing Social Impact Bonds for Medicine
Social finance could provide much-needed incentives for the development of known generic drugs to treat new diseases.



UNaccess.png

Like and share our UN Access to Medicines proposal for a "Generic Drug Repurposing Social Impact Bond

Dr. Stacy Kahn funded for pediatric C-diff research at University of Chicago

90dc7e7090e9496ea1640ed955b7875b.png

Cures Within Reach has secured $40,000 for Dr. Kahn's work to create a patient registry tracking pediatric recurrent Clostridium difficile patients treated with fecal microbiota transplantation.  Repurposing research uses approved drugs, biologics, nutriceuticals, approved devices and diagnostics, and in this case, human flora.   Cures is funding this project in partnership with a private foundation dedicated to improving health for children and dedicated to Chicago area institutions, and has secured additional funds from Goldman Philanthropic Partnerships to help Dr. Kahn pursue a proof concept clinical trial testing swallowed human microbiota capsules as a solution to this life threatening pediatric gastrointestinal infection problem.  
Inaugural CureAccelerator Live! event March 22nd, 2016

CALiveWinner.jpeg

Inspiring repurposing research presentations by six researchers from five Chicago-area institutions.

Dr. George Havelka of the University of Illinois at Chicago and Dr. Darwin Eton presented the winning project, “Saving Limbs: Helping Nature Do Its Magic,” which addresses treatment for chromic limb-threatening ischemia (CLI). CLI patients suffer from impeded blood flow to their limbs, resulting in pain, tissue damage and potentially amputation. The research team has found that combining a compression device with an FDA approved drug used in cancer patients improves patient outcomes and reduces amputation rates. The funding they received will support a clinical study of CLI patients to better understand the molecular effects of the repurposed treatment. Results from this study can then be used to support a larger clinical trial.


Screen-Shot-2016-04-15-at-8-48-43-AM.png